Capsaicin is indicated for:
Peripheral neuropathic pain
Irrespective of gender only Adults (18 years old or older)
Capsaicin is indicated for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Cutaneous - 179-716 mg daily
Active ingredient Capsaicin is contraindicated in the following cases:
No gender/age discrimination
It is unknown whether capsaicin/metabolites are excreted in human milk.
Available pharmacodynamic/toxicological data in animals have shown excretion of capsaicin/metabolites in milk.
A risk to the newborns/infants cannot be excluded.
Breast-feeding should be discontinued during treatment with capsaicin.